General Practitioners criticized Babylon for "cherry-picking patients, leaving traditional GP services to deal with the most complex patients, without sufficient resources to do so". Radiation oncologist Anthony Zietman at Massachusetts General Hospital in Boston has described how the costs of proton-beam therapy distort US health-care markets and channel funds from other areas, such as conventional radiotherapy. My colleagues at King's College London have found that investment in surgical robotics draws funds from other treatments and centralizes care in large teaching hospitals, requiring many patients to travel longer distances or forego care.
The public understands that the pros and cons of technologies are often inextricably linked, that evaluating technologies means deciding whether benefits outweigh the downsides and that doing so depends on how both are distributed. Over more than a decade of using focus groups and participatory exercises to gauge public opinion -on topics from stem cells to nanoscience -I have seen consistently sophisticated assessments of how effects are felt at multiple, interacting scales, from the individual to societal. People worry about the kind of world that technologies will create, not just about harm to individuals. Our policies must show similar sophistication. To me, the UK code is a missed opportunity to start things off right, to anticipate wider, inevitable problems and to keep the health system affordable and effective. It is thanks to the comprehensive National Health Service that the United Kingdom has more than seven decades of data -crucial for developing AI for health care. But these same data also warn that social inequality is detrimental to the physical and mental health of all through increased stress, with documented biological effects of poverty to the brain and body.
Technologies can improve health care, speed up diagnoses and reduce costs. But fulfilling that potential will require us to broaden the lens through which we evaluate them, and soon.
It won't be simple. As with the advent of the car, many serious implications will be emergent, and the harshest effects borne by communities with the least powerful voices. We need to move our gaze from individuals to systems to communities, and back again. We must bring together diverse expertise, including workers and citizens, to develop a framework that health systems can use to anticipate and address issues. This framework needs an explicit mandate to consider and anticipate the social consequences of AI -and to keep watch over its effects. That is the best way to ensure that health technologies meet the needs of all, and not just those in Silicon Valley. ■
